Enanta Pharmaceuticals
ENTA
ENTA
109 hedge funds and large institutions have $103M invested in Enanta Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 38 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6.63% less ownership
Funds ownership: 93.95% → 87.32% (-6.6%)
10% less capital invested
Capital invested by funds: $114M → $103M (-$11.7M)
56% less call options, than puts
Call options by funds: $35K | Put options by funds: $79K
Holders
109
Holding in Top 10
2
Calls
$35K
Puts
$79K
Top Buyers
| 1 | +$2.48M | |
| 2 | +$1.72M | |
| 3 | +$1.43M | |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$851K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$414K |
Top Sellers
| 1 | -$5.97M | |
| 2 | -$4.06M | |
| 3 | -$1.06M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$515K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$492K |
